# Awareness of Venous Thromboembolism in Patients With Cancer and Their Carers: Protocol for Systematic Review

**Authors:** Ann‐Rong Yan, Gregory M. Peterson, Mark Naunton, Phillip Newman, Murray R. Turner, Desmond Yip, Nasser Bagheri, Reza Mortazavi

PMC · DOI: 10.1111/1759-7714.70093 · Thoracic Cancer · 2025-05-22

## TL;DR

This paper outlines a systematic review protocol to assess awareness of venous thromboembolism in cancer patients and their carers.

## Contribution

The study introduces a structured protocol to evaluate VTE awareness and its predictors in cancer populations.

## Key findings

- The review will assess the current state of VTE awareness among cancer patients and carers.
- It will identify factors influencing VTE awareness through a systematic analysis of existing studies.

## Abstract

There is an increased risk of venous thromboembolism (VTE) for people living with cancer. However, the awareness of VTE in this population or their carers appears to be low. This lack of awareness may lead to poor outcomes, such as VTE due to low adherence to thromboprophylaxis or delayed hospital presentations with neglected VTE symptoms. This study protocol will guide researchers in conducting a systematic review of existing studies (quantitative, qualitative, or mixed methods) which have assessed VTE awareness among patients living with cancer or their carers. It will also investigate the rates and predictors of VTE awareness in those populations.

This protocol was designed following the PRISMA‐P 2015 statement and the methodological guidance from the PRISMA 2020 statement. Six databases (APA PsycINFO, CINAHL, Google Scholar, Medline, Scopus, and Web of Science Core Collection) will be searched to retrieve all eligible studies. Covidence software will be utilized to assist in the screening of studies for eligibility. A standard data extraction form will be used, and the Mixed Methods Appraisal Tool (MMAT) will be used to assess the methodological quality of each included study. Both a qualitative descriptive approach and meta‐analysis will be used for data synthesis and integration where possible. The protocol has been registered with PROSPERO (CRD42025628429).

## Linked entities

- **Diseases:** venous thromboembolism (MONDO:0005399), cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** Cancer (MESH:D009369), VTE (MESH:D054556)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12097841/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12097841/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12097841/full.md

---
Source: https://tomesphere.com/paper/PMC12097841